Denifanstat-treated patients also showed statistically significant fibrosis improvement by 1 stage with no worsening of NASH, and a greater proportion of MRI-derived proton density fat fraction (MRI-PDFF) 30% responders relative to placebo
GH therapy leads to a significant reduction in total fat mass, particularly in the abdominal region (Johannsson et al., Journal of Clinical Endocrinology & Metabolism )
That third receptor is the key differentiator, and it is also the most controversial
In contrast to the phosphorylation of ACC2 by AMPK during energy-deficient states, hydroxylation of ACC2 increases under conditions of high glucose content, in particular in skeletal muscle
Nobody believes me, but they absolutely can. GLP-1 drugs are seen as the next top-selling chronic disease treatment, with the potential to transform care the same way cholesterol-lowering statins did for patients at high risk of heart disease more than 30 years ago